Home
Project Initiation
Scientific Impact
About Us
Contact Us
Our Methylome Sequencing Services

Our Methylome Sequencing Services

Sample Requirements and Sequencing Information

Sample Requirements and Sequencing Information

Canadian Bioinformatics Workshop: Bridging Pathology and Genomics: A Practical Workshop on NGS for Pathologists and Pathology Researchers

Canadian Bioinformatics Workshop: Bridging Pathology and Genomics: A Practical Workshop on NGS for Pathologists and Pathology Researchers

Canadian Bioinformatics Workshop: RNA-seq analysis

Canadian Bioinformatics Workshop: RNA-seq analysis

Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors

Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors

A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair—Proficient Colorectal or Pancreatic Cancer

A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair—Proficient Colorectal or Pancreatic Cancer

Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression

Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression

Transcriptomic changes in liver transplant recipients with non-alcoholic steatohepatitis indicate dysregulation of wound healing

Transcriptomic changes in liver transplant recipients with non-alcoholic steatohepatitis indicate dysregulation of wound healing

RBFOX2 Modulates a Metastatic Signature of Alternative Splicing in Pancreatic Cancer

RBFOX2 Modulates a Metastatic Signature of Alternative Splicing in Pancreatic Cancer

A polygenic two-hit hypothesis for prostate cancer

A polygenic two-hit hypothesis for prostate cancer